ArticleJournal of clinical biochemistry and nutrition2025
Short-term intake of delta-tocotrienol on lipid profiles in healthy subjects.
Article in Journal of clinical biochemistry and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Delta-tocotrienol (δ-T3) are beneficial for lipid metabolism. However, there are almost no reports on the specific numerical values of changes in blood tocotrienol levels when Japanese people consume tocotrienol. To observe the effect on blood δ-T3 and lipid concentrations after taking δ-T3, a crossover test was conducted with a control group, alpha-tocopherol (α-TP) group (264 mg/day), and δ-T3 group (250 mg/day). Participants took the target supplements for 14 days. This study revealed that plasma δ-T3 concentrations in healthy men and women increased significantly even with short-term intake (pre; 0.11 ± 0.03 to post; 0.40 ± 0.19 μmol/L). The results of this study showed that α-TP and δ-T3 intake did not significantly affect any of the lipid profiles. However, the intake of δ-T3 tended to increase Low-density lipoprotein cholesterol (HDL-C) levels (pre: 59 ± 17 to post: 64 ± 20 mg/dl). These results provide new evidence on changes in blood δ-T3 concentrations with δ-T3 intake in young people and suggest the potential of δ-T3 for the prevention of atherosclerosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.